
|Slideshows|July 25, 2018
Potential New Biomarker for the Diagnosis of ALS
Author(s)Veronica Hackethal, MD
A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Efgartigimod Shows Non-Inferior Disability Improvement and Greater Muscle Strength Recovery Versus Plasma Exchange in Real-World GBS Study
2
IVIg and Plasma Exchange Show Comparable Functional Outcomes in Guillain-Barre Syndrome
3
The Promise and Limitations of Neurofilament Light Chain in Peripheral Nerve Disorders: Brett Morrison, MD, PhD
4
Neurofilament Light Chain Levels Track Disease Activity and Decline With Efgartigimod Treatment in CIDP
5













